caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1356860290

Kamal Al-EryaniDDS, PHD

Maxillofacial SurgerySan Francisco, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
PRESCRIBING · PART D · 2024
Total Rx claims
642
Beneficiaries
—
Total drug cost
$17K
Distinct drugs
13
Brand share
10.4%
Top prescribed drugs
Clotrimazole190 claims
Dexamethasone142 claims
Chlorhexidine Gluconate76 claims
Clobetasol Propionate40 claims
Lidocaine Hcl34 claims
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
81.1
Cost
71.5
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.42%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
463
Unique beneficiaries
—
Total services
650
Distinct HCPCS
8
Medicare payment
$53K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 31 Maxillofacial Surgery providers in CA — top quintile (cohort median 96).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.